Free Trial

Tango Therapeutics (TNGX) Competitors

Tango Therapeutics logo
$5.69 +0.04 (+0.71%)
Closing price 07/3/2025 03:56 PM Eastern
Extended Trading
$5.69 0.00 (0.00%)
As of 07/3/2025 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TNGX vs. TWST, VCEL, NAMS, DNLI, KNSA, RXRX, APGE, CGON, AGIO, and INDV

Should you be buying Tango Therapeutics stock or one of its competitors? The main competitors of Tango Therapeutics include Twist Bioscience (TWST), Vericel (VCEL), NewAmsterdam Pharma (NAMS), Denali Therapeutics (DNLI), Kiniksa Pharmaceuticals International (KNSA), Recursion Pharmaceuticals (RXRX), Apogee Therapeutics (APGE), CG Oncology (CGON), Agios Pharmaceuticals (AGIO), and Indivior (INDV). These companies are all part of the "pharmaceutical products" industry.

Tango Therapeutics vs. Its Competitors

Twist Bioscience (NASDAQ:TWST) and Tango Therapeutics (NASDAQ:TNGX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

Twist Bioscience has a net margin of -54.98% compared to Tango Therapeutics' net margin of -322.67%. Twist Bioscience's return on equity of -33.48% beat Tango Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Twist Bioscience-54.98% -33.48% -25.34%
Tango Therapeutics -322.67%-62.75%-39.94%

Tango Therapeutics has lower revenue, but higher earnings than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Tango Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Twist Bioscience$312.97M7.30-$208.73M-$3.25-11.73
Tango Therapeutics$42.07M14.66-$130.30M-$1.22-4.66

Twist Bioscience has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500. Comparatively, Tango Therapeutics has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500.

Twist Bioscience presently has a consensus price target of $50.40, suggesting a potential upside of 32.25%. Tango Therapeutics has a consensus price target of $12.20, suggesting a potential upside of 114.41%. Given Tango Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Tango Therapeutics is more favorable than Twist Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Twist Bioscience
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70
Tango Therapeutics
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

79.0% of Tango Therapeutics shares are held by institutional investors. 3.0% of Twist Bioscience shares are held by insiders. Comparatively, 7.5% of Tango Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Tango Therapeutics had 2 more articles in the media than Twist Bioscience. MarketBeat recorded 5 mentions for Tango Therapeutics and 3 mentions for Twist Bioscience. Twist Bioscience's average media sentiment score of 1.08 beat Tango Therapeutics' score of 0.49 indicating that Twist Bioscience is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Twist Bioscience
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tango Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Tango Therapeutics beats Twist Bioscience on 8 of the 15 factors compared between the two stocks.

Get Tango Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNGX vs. The Competition

MetricTango TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$617.85M$2.92B$5.56B$9.05B
Dividend YieldN/A2.44%5.24%3.99%
P/E RatioN/A8.2819.9620.26
Price / Sales14.66283.26419.56119.26
Price / CashN/A41.7026.2128.59
Price / Book3.067.538.035.65
Net Income-$130.30M-$55.14M$3.18B$249.15M
7 Day Performance13.57%4.61%2.93%3.28%
1 Month Performance33.57%0.90%1.72%3.95%
1 Year Performance-33.53%5.40%34.39%20.98%

Tango Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNGX
Tango Therapeutics
1.9764 of 5 stars
$5.69
+0.7%
$12.20
+114.4%
-33.5%$617.85M$42.07M0.0090Analyst Revision
TWST
Twist Bioscience
4.4645 of 5 stars
$36.79
+2.4%
$50.40
+37.0%
-21.4%$2.15B$312.97M-11.32990Positive News
VCEL
Vericel
2.8341 of 5 stars
$42.55
+2.0%
$61.14
+43.7%
-10.5%$2.10B$237.22M1,418.81300News Coverage
Positive News
NAMS
NewAmsterdam Pharma
2.2741 of 5 stars
$18.11
-2.5%
$42.89
+136.8%
-0.8%$2.08B$45.56M-9.634Analyst Upgrade
DNLI
Denali Therapeutics
4.6319 of 5 stars
$13.99
-0.8%
$33.71
+141.0%
-30.5%$2.05B$330.53M-5.24430Positive News
KNSA
Kiniksa Pharmaceuticals International
3.2836 of 5 stars
$27.67
-1.3%
$38.80
+40.2%
+43.9%$2.05B$423.24M-110.68220Analyst Upgrade
RXRX
Recursion Pharmaceuticals
1.9157 of 5 stars
$5.06
+0.6%
$7.00
+38.3%
-28.1%$2.04B$58.84M-2.86400Analyst Forecast
APGE
Apogee Therapeutics
2.8711 of 5 stars
$43.43
+0.1%
$94.60
+117.8%
+25.1%$2.00BN/A-12.0691News Coverage
Analyst Forecast
Insider Trade
High Trading Volume
CGON
CG Oncology
2.3486 of 5 stars
$26.00
+0.2%
$58.67
+125.6%
-15.6%$1.98B$1.14M-17.2261
AGIO
Agios Pharmaceuticals
4.0117 of 5 stars
$33.26
-0.6%
$58.60
+76.2%
-15.5%$1.94B$36.50M2.96390Insider Trade
INDV
Indivior
2.052 of 5 stars
$14.74
+5.7%
$17.00
+15.3%
+6.5%$1.92B$1.19B-47.551,051News Coverage
High Trading Volume

Related Companies and Tools


This page (NASDAQ:TNGX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners